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Background: Arsenic is a ubiquitous environmental toxicant, and abnormalities of the skin 
are the most common outcomes of long-term, low-dose, chronic arsenic exposure. If the bal-
ance between keratinocyte proliferation, differentiation, and death is perturbed, pathologic 
changes of the epidermis may result, including psoriasis, atopic dermatitis, and certain forms 
of ichthyosis. Therefore, research investigations using in vitro human epidermal cells could 
help elucidate cellular and molecular processes in keratinocytes affected by arsenic. Data from 
such investigations could also provide the basis for developing cosmetic intervention for skin 
diseases caused by arsenic.
Methods: The viability of HaCaT keratinocyte cultures with or without prior exposure to 
low-dose arsenic trioxide was compared for varying concentrations of arsenic trioxide over a 
time course of 14 days because in untreated control cultures, approximately 2 weeks is required 
to complete cell differentiation. Long-term cultures were established by culturing HaCaT cells 
on collagen IV , and cells were subsequently exposed to 0 parts per million (ppm), 1 ppm, 5 ppm, 
7.5 ppm, 10 ppm, and 15 ppm of arsenic trioxide. The percentages of viable cells as well as 
DNA damage after exposure were determined on Day 2, Day 5, Day 8, and Day 14.
Results: Using both statistical and visual analytics approaches for data analysis, we have 
observed a biphasic response at a 5 ppm dose with cell viability peaking on Day 8 in both 
chronic and acute exposures. Further, a low dose of 1 ppm arsenic trioxide enhanced HaCaT 
keratinocyte proliferation, whereas doses above 7.5 ppm inhibited growth.
Conclusion: The time course profiling of arsenic trioxide cytotoxicity using long-term HaCaT 
keratinocyte cultures presents an approach to modeling the human epidermal cellular responses 
to varying doses of arsenic trioxide treatment or exposure. A low dose of arsenic trioxide appears 
to aid cell growth but concomitantly disrupts the DNA transcription process.
Keywords: arsenic trioxide, chronic exposure, DNA damage, HaCaT, keratinocyte, visual 
analytics
Introduction
Arsenic is a ubiquitous environmental toxicant, and abnormalities of the skin are the 
most common outcomes of long-term, low-dose, chronic arsenic exposure.1–3 The com-
mon dermatological symptoms of arsenicosis are hyperpigmentation, hyperkeratosis, 
keratosis on the soles, keratosis on the palms, melanosis, hypopigmentation on the 
trunk and dorsal surface extremities,4 and keratosis of the genitalia and eyelids.2 The 
major routes of exposure are through inhalation and ingestion through food, drinking 
water, and medication.5,6 Skin malignancies linked to arsenic include squamous cell 
carcinomas, basal cell carcinomas, Merkel cell carcinoma, intraepidermal carcinomas 
(Bowen disease),7,8 and multiple cutaneous malignancies.9,10
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The maturation and differentiation of keratinocytes 
from the stem cells in the basal layer of the epidermis to the 
corneocytes or squamous cells at the outermost layer of the 
skin follow an organized system and take approximately 
14 days.11 The stratum corneum, which contains corneocytes 
and extracellular lipids secreted by differentiated keratino-
cytes, plays a vital immunologic role in the body, acting as a 
barrier against the entry of chemicals and microbes from the 
environment and protecting the body from dehydration.12 The 
epithelial keratinocytes are the first cells to come into contact 
with arsenic through ingestion, inhalation, or direct contact, 
thus explaining why they are the most affected cells.
If the balance between keratinocyte proliferation, differ-
entiation, and death is perturbed, pathologic changes of the 
epidermis may result, including psoriasis, atopic dermatitis, 
and certain forms of ichthyosis.13 Therefore, research inves-
tigations using in vitro human epidermal cells could help 
elucidate cellular and molecular processes in keratinocytes 
affected by arsenic. Data from such investigations could also 
provide the basis for developing a cosmetic intervention for 
skin diseases caused by arsenic.
The HaCaT cell line is an immortalized human skin epithe-
lial cell line that exhibits normal keratinocyte differentiation, 
which makes it a useful in vitro model system for determining 
regulatory mechanisms during human epidermal cell dif-
ferentiation.14 Inorganic arsenic is cytotoxic and genotoxic to 
keratinocytes and thus able to perturb normal human epidermal 
cell growth and differentiation.15–18 Arsenic trioxide is an inor-
ganic arsenic effectively used in the treatment of skin-related 
diseases such as psoriasis and syphilis-associated skin rashes.19 
Topical application of arsenic trioxide has been proposed as 
an effective and safe radiosensitizer for palliative radiotherapy 
for skin-infiltrating lesions of breast cancer.20 Prolonged use 
of arsenic trioxide for the treatment of acute promyelocytic 
leukemia causes side effects including skin dryness, itching, or 
erythematous changes, and acute toxicity could lead to acute 
fluid retention, skin rash, kidney failure, and sudden death.21
The objective of the research was to compare the cytotoxic 
effect of various concentrations of arsenic trioxide on HaCaT 
keratinocytes with or without prior exposure to low-dose arse-
nic trioxide for ten passages. In this experiment, the chronic 
cell state was established by exposing HaCaT keratinocytes 
to a low dose (0.5 parts per million [ppm]) of arsenic over 10 
passages, simulating how people in endemic areas are naturally 
exposed through drinking water. Long-term cultures were 
established by culturing HaCaT cells on collagen IV and were 
subsequently exposed to various concentrations (0 ppm, 1 ppm, 
5 ppm, 7.5 ppm, 10 ppm, and 15 ppm) of arsenic trioxide. 
The DNA damage after exposure to various concentrations 
of arsenic trioxide was determined. Also determined were 
the percentages of viable cells on Day 2, Day 5, Day 8, and 
Day 14 cultures. The time course time points were selected 
based on Rea et al22 in which the effect of arsenate on normal 
human epidermal keratinocytes were determined over a time 
course of approximately 2 weeks. Untreated control cultures 
maximally express differentiation markers in 14 days.22 The 
dose (0.5 ppm) of arsenic selected for establishing chronic 
HaCaT culture was consistent with the range of arsenic levels 
in drinking water in endemic areas of Bangladesh, India, and 
Taiwan, which is from 0.05 ppm to 3.4 ppm.23–25
Material and methods
Chemical and reagents
Arsenic trioxide (99.9% purity, Fisher Scientific, Suwanee, 
GA), fetal bovine serum, Dulbecco’s Modified Eagle’s Medium 
(DMEM), phosphate buffered solution (PBS 1x) (American 
Type Culture Collection [ATCC], Manassas, VA), and strep-
tomycin/penicillin antibiotics (Invitrogen, Carlsbad, CA) 
were purchased for culturing the HaCaT cell line. The 3-(4, 
5-dimethylthiazol-2-yl)-2, 5-  diphenyltetrazoliumbromide 
(MTT) reagent was obtained from ATCC and collagen IV 
from Sigma Chemical Company (St Louis, MO).
Cell culture
HaCaT keratinocytes were kindly provided by Dr Van Wilson 
(Microbial and Molecular Pathogenesis, College of Medi-
cine, Texas A&M Health Science Center, College Station, 
TX). Approximately 1.5 × 105 HaCaT cells were cultured 
in 7.5 mL of complete DMEM in T-25 culture flasks and 
incubated in a humidified atmosphere with 5% CO2 at 37°C. 
The culture medium was replaced every 96 hours. The cells 
were split after growing to 90% confluence by aspirating 
the culture medium and washing the cell monolayer three 
times with sterile PBS. The cell monolayer was treated with 
1 mL 0.25% trypsin-EDTA per plate and incubated briefly 
at 37°C. The cells were then viewed under the microscope 
to ensure that cells were completely detached and were 
resuspended in a complete DMEM medium. An aliquot of 
the HaCaT cell suspension was stained with 4% trypan blue 
for 1 to 2 minutes and counted with a   hemocytometer. The 
cells used for chronic exposure were considered chronic 
after undergoing ten passages (cells trypsinized at 90% 
confluence and subcultured in another cultured flask). In 
this research investigation, acute cells are defined as the 
cells that were exposed to arsenic trioxide for the first time, 
whereas chronic cells are cells that have been exposed 
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continuously to up to ten passages with a very low-dose 
0.5 ppm of arsenic trioxide.
Collagen coating
Collagen coating was performed using Kleinman’s method:26 
75 µL of collagen IV (30 ppm) was transferred to prechilled 
wells of 96-well tissue culture plates. The solution was evenly 
spread to completely cover the flat bottom of the wells. The 
plates were incubated at 37°C for 2 hours and washed three 
times with sterile PBS.
Cytotoxicity assay
Arsenic trioxide (arsenic trioxide dissolved in dilute nitric 
acid, 1 mL = 1 mg AS; Reference Standard Solution, 1000 
ppm +/−1%/certified, 99.9% purity, Fisher Scientific) dilu-
tions were prepared using a complete DMEM medium as 
the diluent. Eight different 96-well plates were used for the 
different time points: four different 96-well plates were labeled 
Day 2+AS, Day 5+AS, Day 8+AS, and Day 14+AS for the 
chronic cells treatment group; and an additional four different 
96-well plates were labeled Day 2−AS, Day 5−AS, Day 8−AS, 
and Day 14−AS for the acute cells, cells without previous 
arsenic exposure (+AS = with arsenic and −AS = without pre-
vious arsenic exposure). Column 1 of the precollagen-coated 
96-well plates was used for media alone, column 2 for media 
and cells (cells grown in culture medium without arsenic, 
which served as passage-matched control group), and columns 
3–12 for the various concentrations of arsenic   trioxide. Each 
of the concentrations was performed in   triplicate. A total of 
200 µL complete medium only was added to the first column, 
then 100 µL of HaCaT cell suspension in complete medium 
containing approximately 20,000 cells/well was added to 
column 3–12 wells of the precollagen-coated 96-well plates, 
100 µL of medium was added to column 2, and 100 µL of 
arsenic trioxide concentrations was added to columns 3–12, 
ensuring that the final concentrations were 0, 1.0, 5.0, 7.5, 
10, and 15 ppm, respectively. They were incubated in a 
humidified incubator at 37°C in a 5% CO2 for a period of 
2 days, 5 days, 8 days, and 15 days. Arsenic has a very short 
half-life of approximately 5 days;27 consequently, medium 
and arsenic were replaced every 4 days to maintain arsenic 
concentration level and nutrient for the cells, thus removing 
any confounding factor that may come from depleted nutrients 
and cell metabolism waste.
At each of the time points, the culture plate was removed 
from the incubator and 10 µL of the yellow MTT reagent was 
added to each of the wells and incubated at 37°C for 4 hours 
until purple formazan precipitate was visible. Then 100 µL of 
the detergent reagent was added to each of the wells and kept 
in the dark at room temperature for 2 hours. The absorbance 
was measured at 570 nm wave length using a microtiter plate 
reader (Fluoroskan II microplate reader, Helsinki, Finland). 
LD10 and LD50 were determined from the dose-response 
curve. The experiment was repeated using chronic HaCaT 
cells (HaCaT that have been exposed to low-dose 0.5 ppm 
arsenic trioxide for up to ten passages).
Single gel electrophoresis (Comet Assay)
Single gel electrophoresis was performed to determine DNA 
damage in HaCaT cells when exposed to arsenic trioxide 
using a Comet Assay kit (Trevigen Inc, Gaithersburg, MD). 
The manufacturer’s protocol was followed to conduct the 
experiment. About 1.5 × 105 HaCaT cells were cultured 
in 7.5 mL of complete DMEM in a T-25 culture flask and 
incubated in a humidified atmosphere with 5% CO2 at 37°C. 
After growing to 80% confluence, the DMEM was aspirated 
and replaced with different concentrations of arsenic trioxide 
diluted in complete DMEM (0, 1, 5, 7.5, 10, and 15 ppm) 
and incubated for 48 hours. The untreated HaCaT Cells 
(0 ppm) served as the DNA damage control. After arsenic 
trioxide treatments, the medium was removed and the cells 
were washed three times with prechilled PBS and trypsinized 
with 1 mL of 0.25% trypsin-EDTA and then transferred to 
a centrifuge tube and counted. The cells were centrifuged at 
3000 rpm for 5 minutes and washed once in ice-cold PBS.
The pellet was resuspended in ice-cold PBS at 1 × 105 
cells/mL. The cells were mixed with molten LMAgarose (at 
37°C) at a ratio of 1:10 (v/v), and 50 µL was immediately 
pipetted onto precoated CometSlide™ (Trevigen Inc, Gaith-
ersburg, MD). The slides were placed flat in a refrigerator at 
4°C in the dark for 30 minutes. The slides were immersed in a 
prechilled lysis solution and left on ice for 60 minutes. Excess 
buffers were drained from the slides and then immersed in a 
freshly prepared alkaline solution, pH . 13 (0.6 g of NaOH 
pellets, 250 µL of 200 mM EDTA, and 49.75 mL of dH2O) 
for 60 minutes at room temperature. Slides were washed 
twice for 5 minutes with 1X TBE (Tris-Borate-EDTA neu-
tral buffer) electrophoresis buffer. The slides were aligned 
equidistant from electrodes in a horizontal gel apparatus and 
1X TBE was added and electrophoresed at 1 V/cm (22 V) for 
10 minutes. Excess TBE was tapped out and the slides were 
immersed twice in distilled water for 10 minutes and in 70% 
ethanol for 5   minutes. Excess 70% ethanol was removed and 
the slides were air dried overnight and stained with 100 µL 
of diluted SYBR Green and placed in the refrigerator for 
5 minutes, removed, and tapped to remove SYBR Green. 
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Slides were allowed to air dry at room temperature in the 
dark. The slides were examined using an Olympus Epif-
luorescence Microscope, and the LAI’s Automated Comet 
Assay Analysis System (LACAAS) (Loates Associates, 
Inc, Westminster, MD) was used to determine the extent 
of DNA damage by measuring the percent DNA in the tail 
(the integrated tail intensity × 100/the total integrated cell 
intensity for a normalized measure of the percent of total cell 
DNA found in the tail),28 comet moment (% DNA in tail x 
tail length), and tail length (the distance of DNA migration 
from the body of the nuclear core).28 Seventy comets were 
randomly selected from each slide for statistical analysis, 
and photographs were taken to show the changes in DNA 
morphology due to exposure to arsenic trioxide. Experiments 
were conducted in triplicate.
Statistical analysis
The absorbance values obtained per treatment from the MTT 
assay were converted to percentages of cell viability. Statisti-
cal analysis for differences in mean levels of arsenic trioxide 
was done using the Student’s t-test for comparing two sample 
sets at P , 0.05. The data generated from the Comet assay 
were analyzed by using the two-sample F-test for variance 
of the treated and untreated (control) HaCaT cells and the 
significance level was P , 0.05.
Visual analytics
Visual analytics is increasingly used to analyze multidimen-
sional biological datasets of all sizes and presenting them in 
an interactive visual display with one of the purposes being 
to identify patterns.29–31 For example, paired analysis permits 
analysis within and between datasets. Tools available in the 
Tableau Public Software (http://www.tableausoftware.com/
public) were used to visualize the cytotoxicity data produced 
from the experimental results.
Results
Long-term cultures were established by culturing HaCaT 
cells on collagen IV. MTT cytotoxicity assay was used to 
evaluate chronic toxicity of arsenic trioxide on keratinocytes. 
An LD10 value was obtained with a 1 ppm dose, and a dose 
of 0.5 ppm arsenic trioxide was used to establish the chronic 
HaCaT cells for up to ten passages. Two visual analytic repre-
sentations of the cell viability data are presented in Figures 1 
and 2. Figure 1 presents a time course for each dose, whereas 
Figure 2 presents a view comparing the exposure types for 
each time point and concentration. In addition,   Figures 3 
and 4 presents the cytotoxicity data as a bar chart with error 
bars shown. Overall, in both acute and chronic   exposure, the 
HaCaT cell viability was dose dependent. Thus, an increase 
in dose resulted in decreased cell viability. The 1 ppm dose in 
the acute treatment cells resulted in 92.4% viability on Day 2, 
and cells continued to grow in the time course with viability 
rates of 93.4%, 107%, and 115.9% for Days 5, 8, and 14, 
respectively (Figures 1–3). The 5 ppm concentration resulted 
in viability rates of 30.8%, 36%, 46.7%, and 32.7% for Day 
2, Day 5, Day 8, and Day 14 time points respectively.
Treatment doses of 7.5 ppm, 10 ppm, and 15 ppm inhib-
ited growth of both acute and chronic cells (Figures 1 and 2). 
In the chronic treatment cells, the 1 ppm dose gave viability 
rates of 92.1%, 98.5%, 114.5%, and 120% for Days 2, 5, 8, 
and 14, respectively, whereas the 5 ppm gave viability rates 
of 42.9%, 45.9%, 67.1%, and 56.7% for Days 2, 5, 8, and 14, 
respectively (Figures 1, 2, and 4). The chronic cell had higher 
viability values that could resist the cytotoxic effect of the 
high doses of 7.5 ppm, 10 ppm, and 15 ppm. There was no 
significant difference at P , 0.05 when the chronic HaCaT 
cells were compared with the acute HaCaT cells at the vari-
ous time points except for the 5 ppm dose using the Student’s 
t-test. Additionally, there was no significant difference when 
the controls were compared with the 1 ppm dose in both acute 
and chronic cells at P , 0.05. However, there are significant 
differences at P , 0.05 on Day 2 between the controls and 
other treatment groups: 5 ppm, 7.5 ppm, 10 ppm, and 15 ppm 
in both acute and chronic cells.
Figure 2 illustrates a time course cell viability pattern, 
showing acute versus chronic exposure to arsenic trioxide. 
Chronic HaCaT cells were more tolerant to the 5 ppm dose 
compared with the acute HaCaT cells. A low dose of 1 ppm 
was observed to improve cell viability, whereas high doses 
above 5 ppm were toxic to both chronic and acute HaCaT 
cells.
Comet Assay was performed in HaCaT cells exposed 
to different concentrations of arsenic trioxide to determine 
the dose that has the highest genotoxic effect on HaCaT 
cells. Comet Assay was done using TBE, a neutral buffer 
that produces elongated comet shape, stained with SYBR® 
Green and images generated and measured automatically on 
a Loats System. The parameters measured in the 70 comets 
randomly selected per sample were the moment, comet tail 
length, and DNA damage. There was an increase in the length 
and rate of DNA migration in the HaCaT cells treated with 
arsenic trioxide when compared with the untreated control 
HaCaT cell.
The Comet Assay result shows a dose-dependent response to 
arsenic trioxide exposure as shown in Figure 4. The   percentage 
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Figure 1 Dose- and time-dependent response to the cytotoxic effect of arsenic trioxide on HaCaT keratinocytes. Interactive visual analytics resource for image available at 
http://public.tableausoftware.com/views/hacat_arsenic/viability_timecourse.
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DNA damage results were 0.27%, 3.45%, 3.22%, 4.0%, 
7.5%, and 11% for 0 ppm, 1 ppm, 5 ppm, 7.5 ppm, 10 ppm, 
and 15 ppm, respectively. There was a significant difference 
in DNA damage between the control and the treatment doses 
at (P , 0.05) using two-sample F-test for variance. A similar 
pattern was observed for comet moment and comet tail length 
results. Images representing the comets observed are shown in 
Figure 5 and values in Table 1. In Figure 5, panel A represents 
a comet from the untreated cell control, moment 0.0, % DNA 
0.08, length 0.0; panel B represents 1 ppm, moment 0.04, % 
DNA 2.1, length 5; and panel C represents 15 pp, moment 
8.18, % DNA 28.62, length 73.
Discussion
We have established chronic cultures of HaCaT cells treated 
with 0.5 ppm arsenic trioxide up to passage ten and sub-
sequently exposed the chronic HaCaT cells and untreated 
control HaCaT cells to higher doses of arsenic trioxide. 
Visual analytics software was used to construct interac-
tive visualizations of the acute and chronic exposures at 
the various time points (Figures 1 and 2) and to demonstrate 
the genotoxic effect of arsenic on HaCaT cells (Figures 5 
and 6). The visual analytics resources in this report, unlike 
the standard static figures, will allow for user-defined queries 
beyond those reported here. The visualization could help 
generate hypothesis from novel insights on the patterns of 
arsenic cytotoxicity as the cells mature and differentiate from 
basal cell to squamous cells.
Our results confirmed that arsenic trioxide is cytotoxic to 
HaCaT cells.17 We observed a biphasic response at a 5 ppm 
dose with cell viability peaking on Day 8 in both chronic 
cells and acutely exposed cells. It is striking that a low dose 
of 1 ppm arsenic trioxide enhanced HaCaT keratinocyte 
proliferation and doses above 7.5 ppm inhibited growth. This 
observation concurs with previous reports,17,32 but the time 
course profiling of arsenic trioxide cytotoxicity using long-
term HaCaT cell cultures provides an approach to modeling 
the human epidermal cellular response to varying doses of 
arsenic trioxide exposure.
At low concentrations, arsenic trioxide regulated the 
expression of cell cycling pathway genes such as cyclin-
dependent kinase 4 and transcription factor 1,16 and this may 
explain the observation with the 1 ppm dose. Additionally, 
in our previous microarray gene expression investigation,33 
long-term exposure of HaCaT cells to low-dose 0.5 
ppm of arsenic trioxide up to 22 passages enhanced the 
upregulation of insulin growth factor-like family member 
1 (IGFL1), which was confirmed with the quantitative 
reverse transcription polymerase chain reaction method. 
A B C
Comet head: 1 1
Comet tail:     1 1 
Figure 5 Representative comets from exposure of HaCaT keratinocytes to con-
centrations of arsenic trioxide. Panel A represents a comet from the untreated cell 
(control), Panel B represents 1 ppm, and Panel C represents 15 ppm treated cells.
Table  1  Summary  of  Comet  Assay  data  showing  percentage 
DnA damage of HaCaT cells exposed to arsenic trioxide
Concentration (ppm) % DNA Length Moment
0 0.27 2.00 0.26
1 3.45 3.00 0.97
5 3.22 4.50 1.03
7.5 4.00 4.50 5.00
10 7.50 6.50 2.34
15 11.00 10.00 9.00
Note: Data in table can be downloaded at: http://public.tableausoftware.com/views/
hacat_arsenic/comet_table.
Abbreviation: ppm, parts per million.
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Figure 3 Dose- and time-dependent response of HaCaT keratinocytes without 
prior exposure to low dose (0.5 parts per million [ppm]) of arsenic trioxide over 
ten passages.
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Figure 4 Dose- and time-dependent response of HaCaT keratinocytes with prior 
exposure to low dose (0.5 parts per million [ppm]) of arsenic trioxide over ten 
passages.
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IGFL1 similar to other related IGF is involved in cellular 
energy metabolism, growth and   development, and promotion 
of cell division.34 IGFL1 is known to be upregulated in skin 
conditions such as psoriasis that promote the abnormal pro-
liferation and differentiation of epidermal keratinocytes.35,36 
Additionally, the observed increase in cell proliferation at a 
1 ppm dose could be attributed to induction of cyclin D1 
transcription by low-dose arsenic as reported by Hwang 
et al.37 Cyclin D1 stimulates growth by shifting the G1 
growth phase into the S/G2 cell cycle compartment. 
A similar observation had been made with arsenic trioxide 
on porcine aortic endothelial cells, in which low concen-
trations stimulated cell proliferation with increases in 
superoxide and hydrogen peroxide (H2O2) accumulation, 
H2O2-dependent tyrosine phosphorylation, and NF-κB-
dependent transcription.38
There was a significant difference between the control 
cell and the 1 ppm dose in the Comet Assay (P , 0.05). 
Our results show that arsenic trioxide has differential 
effects on cell growth and DNA damage depending on its 
concentration.3,39 Arsenic dose-dependent effects have been 
observed on telomerase activity where low doses result in an 
increase in activity observed as elongated telomere length 
and promotion of cell proliferation, whereas at high doses of 
arsenic, telomerase activity is reduced with reduced telomere 
length and cell death induction.18 Telomere homeostasis is 
critical in maintaining chromosome and genomic stability.40,41 
In normal nontransformed normal human epidermal keratino-
cytes (NHEK) Comet assay, arsenite was reported to induce 
cell proliferation by increasing redox-related gene expression 
and decreasing DNA repair.42 Therefore, low concentrations 
of arsenic trioxide can significantly enhance HaCaT kerati-
nocyte proliferation.
Conclusion
Long-term exposure of HaCaT cells to low-dose #1.0 ppm 
of arsenic trioxide may enhance cell proliferation, but higher 
doses are cytotoxic. A low dose of arsenic trioxide appears 
to aid cell growth but concomitantly disrupts the DNA tran-
scription process.
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